Global IVF Market Growth (Status and Outlook) 2023-2029
In vitro fertilisation (IVF) is a process of fertilisation where an egg is combined with sperm outside the body, in vitro ("in glass"). The process involves monitoring and stimulating a woman's ovulatory process, removing an ovum or ova (egg or eggs) from the woman's ovaries and letting sperm fertilise them in a liquid in a laboratory. The fertilised egg (zygote) undergoes embryo culture for 2–6 days, and is then transferred to the same or another woman's uterus, with the intention of establishing a successful pregnancy.
LPI (LP Information)' newest research report, the “IVF Industry Forecast” looks at past sales and reviews total world IVF sales in 2022, providing a comprehensive analysis by region and market sector of projected IVF sales for 2023 through 2029. With IVF sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world IVF industry.
This Insight Report provides a comprehensive analysis of the global IVF landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on IVF portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global IVF market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for IVF and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global IVF.
The global IVF market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual estimates and forecasts are provided for the period 2018 through 2025. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for IVF in US$ by following Product Segments.: Intracytoplasmic Sperm Injection (ICSI), Frozen Embryo Replacement (FER) and Pre-implantation Genetic Diagnosis (PGD)
Company profiles are primarily based on public domain information including company
Vitrolife AB
EMD Serono Inc
Irvine scientific
Cooper Surgical Inc
Cook Medical Inc
Thermo Fisher Scientific Inc
Genea Biomedx
Auxogyn, Inc
Oxford Gene Technology
Ovascience
This report presents a comprehensive overview, market shares, and growth opportunities of IVF market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Intracytoplasmic Sperm Injection (ICSI)
Frozen Embryo Replacement (FER)
Pre-implantation Genetic Diagnosis (PGD)
Segmentation by application
Clone
Transgenic
Embryonic Stem Cell Isolation and Culture
Test Tube Baby
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Vitrolife AB
EMD Serono Inc
Irvine scientific
Cooper Surgical Inc
Cook Medical Inc
Thermo Fisher Scientific Inc
Genea Biomedx
Auxogyn, Inc
Oxford Gene Technology
Ovascience
Please note: The report will take approximately 2 business days to prepare and deliver.